DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Short Term Provisions | ₹850 Cr | ₹527 Cr | ₹445 Cr | ₹1,265 Cr | ₹624 Cr |
What is the latest Short Term Provisions ratio of DIVIS LABORATORIES ?
Year | Short Term Provisions |
---|---|
Mar2025 | ₹850 Cr |
Mar2024 | ₹527 Cr |
Mar2023 | ₹445 Cr |
Mar2022 | ₹1,265 Cr |
Mar2021 | ₹624 Cr |
How is Short Term Provisions of DIVIS LABORATORIES Trending?
Years | Short Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹850 Cr | 61.29 | |
Mar2024 | ₹527 Cr | 18.43 | |
Mar2023 | ₹445 Cr | -64.81 | |
Mar2022 | ₹1,265 Cr | 102.56 | |
Mar2021 | ₹624 Cr | - |
Compare Short Term Provisions of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹162,014.7 Cr | 1.3% | 0.3% | 10.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,626.0 Cr | 2% | 1.4% | -13% | Stock Analytics | |
CIPLA | ₹127,494.0 Cr | 0.3% | 1.9% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,718.0 Cr | 0% | -2.3% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,374.0 Cr | 0.5% | 6.2% | -1.4% | Stock Analytics | |
MANKIND PHARMA | ₹108,892.0 Cr | 2.3% | 5.9% | 4.6% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1.3% |
0.3% |
10.4% |
SENSEX | 1.8% |
2.1% |
0.2% |
You may also like the below Video Courses